{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:50:36Z","timestamp":1792785036468,"version":"4.5.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Immunological mechanisms and diagnostic applications of activation of latent tuberculosis infection in special populations","award":["SKL-HIDCA-2021-JH12"],"award-info":[{"award-number":["SKL-HIDCA-2021-JH12"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-98152-3","type":"journal-article","created":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T02:22:59Z","timestamp":1745893379000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Identification of immune phenotypes and diagnostic biomarkers in active and latent tuberculosis infections"],"prefix":"10.1038","volume":"15","author":[{"given":"Tongtong","family":"Shao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ge","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobo","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongjiong","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,29]]},"reference":[{"issue":"19","key":"98152_CR1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI173156","volume":"133","author":"BN Koleske","year":"2023","unstructured":"Koleske, B. N., Jacobs, W. R. & Bishai, W. R. The Mycobacterium tuberculosis genome at 25 years: Lessons and lingering questions. J. Clin. Investig. 133(19), e173156 (2023).","journal-title":"J. Clin. Investig."},{"issue":"4","key":"98152_CR2","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1016\/S1473-3099(21)00810-0","volume":"22","author":"F Cobelens","year":"2022","unstructured":"Cobelens, F. et al. Accelerating research and development of new vaccines against tuberculosis: A global roadmap. Lancet Infect. Dis. 22(4), e108\u2013e120 (2022).","journal-title":"Lancet Infect. Dis."},{"issue":"1","key":"98152_CR3","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.419","volume":"5","author":"L Zhuang","year":"2024","unstructured":"Zhuang, L. et al. Mycobacterium tuberculosis: Immune response, biomarkers, and therapeutic intervention. MedComm 5(1), e419 (2024).","journal-title":"MedComm"},{"issue":"3","key":"98152_CR4","doi-asserted-by":"publisher","first-page":"e64","DOI":"10.1016\/S1473-3099(17)30623-0","volume":"18","author":"L Abel","year":"2018","unstructured":"Abel, L. et al. Genetics of human susceptibility to active and latent tuberculosis: Present knowledge and future perspectives. Lancet Infect. Dis. 18(3), e64\u2013e75 (2018).","journal-title":"Lancet Infect. Dis."},{"issue":"1","key":"98152_CR5","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/CMR.00100-19","volume":"33","author":"SB Sable","year":"2019","unstructured":"Sable, S. B., Posey, J. E. & Scriba, T. J. Tuberculosis vaccine development: Progress in clinical evaluation. Clin. Microbiol. Rev. 33(1), 10\u20131128 (2019).","journal-title":"Clin. Microbiol. Rev."},{"issue":"1","key":"98152_CR6","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13568-024-01691-7","volume":"14","author":"C Liu","year":"2024","unstructured":"Liu, C. & Li, X. Identification of hub genes and establishment of a diagnostic model in tuberculosis infection. AMB Express 14(1), 36 (2024).","journal-title":"AMB Express"},{"issue":"20","key":"98152_CR7","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.166242","volume":"8","author":"CK Bullen","year":"2023","unstructured":"Bullen, C. K. et al. MDA5 RNA-sensing pathway activation by Mycobacterium tuberculosis promotes innate immune subversion and pathogen survival. JCI Insight 8(20), e166242 (2023).","journal-title":"JCI Insight"},{"issue":"7309","key":"98152_CR8","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1038\/nature09247","volume":"466","author":"MP Berry","year":"2010","unstructured":"Berry, M. P. et al. An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature 466(7309), 973\u2013977 (2010).","journal-title":"Nature"},{"issue":"1","key":"98152_CR9","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.1038\/s41467-018-04579-w","volume":"9","author":"A Singhania","year":"2018","unstructured":"Singhania, A. et al. A modular transcriptional signature identifies phenotypic heterogeneity of human tuberculosis infection. Nat. Commun. 9(1), 2308 (2018).","journal-title":"Nat. Commun."},{"issue":"5","key":"98152_CR10","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/ni.3693","volume":"18","author":"JC Rieckmann","year":"2017","unstructured":"Rieckmann, J. C. et al. Social network architecture of human immune cells unveiled by quantitative proteomics. Nat. Immunol. 18(5), 583\u2013593 (2017).","journal-title":"Nat. Immunol."},{"issue":"2","key":"98152_CR11","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.chom.2020.11.013","volume":"29","author":"E Esaulova","year":"2021","unstructured":"Esaulova, E. et al. The immune landscape in tuberculosis reveals populations linked to disease and latency. Cell Host Microbe 29(2), 165\u2013178 (2021).","journal-title":"Cell Host Microbe"},{"issue":"D1","key":"98152_CR12","doi-asserted-by":"publisher","first-page":"D672","DOI":"10.1093\/nar\/gkae909","volume":"53","author":"M Kanehisa","year":"2025","unstructured":"Kanehisa, M. et al. KEGG: Biological systems database as a model of the real world. Nucleic Acids Res. 53(D1), D672\u2013D677 (2025).","journal-title":"Nucleic Acids Res."},{"issue":"5","key":"98152_CR13","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nmeth.3337","volume":"12","author":"AM Newman","year":"2015","unstructured":"Newman, A. M. et al. Robust enumeration of cell subsets from tissue expression profiles. Nat. Methods 12(5), 453\u2013457 (2015).","journal-title":"Nat. Methods"},{"key":"98152_CR14","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/6680651","volume":"2021","author":"M Barry","year":"2021","unstructured":"Barry, M. Prevalence of latent tuberculosis infection in the Middle East and North Africa: A systematic review. Pulm. Med. 2021, 6680651 (2021).","journal-title":"Pulm. Med."},{"issue":"4","key":"98152_CR15","doi-asserted-by":"publisher","first-page":"616","DOI":"10.3390\/genes13040616","volume":"13","author":"S Natarajan","year":"2022","unstructured":"Natarajan, S. et al. Transcriptional profiling and deriving a seven-gene signature that discriminates active and latent tuberculosis: An integrative bioinformatics approach. Genes (Basel) 13(4), 616 (2022).","journal-title":"Genes (Basel)"},{"issue":"5","key":"98152_CR16","doi-asserted-by":"publisher","first-page":"e1162","DOI":"10.1093\/infdis\/jiae254","volume":"230","author":"S Petrillo","year":"2024","unstructured":"Petrillo, S. et al. Redox biomarkers in asymptomatic latent human tuberculosis: A comparison with active disease. J. Infect. Dis. 230(5), e1162\u2013e1170 (2024).","journal-title":"J. Infect. Dis."},{"key":"98152_CR17","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1146\/annurev-immunol-032712-095939","volume":"31","author":"A O\u2019Garra","year":"2013","unstructured":"O\u2019Garra, A. et al. The immune response in tuberculosis. Annu. Rev. Immunol. 31, 475\u2013527 (2013).","journal-title":"Annu. Rev. Immunol."},{"key":"98152_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.923492","volume":"13","author":"M Qiao","year":"2022","unstructured":"Qiao, M. et al. Delamanid suppresses CXCL10 expression via regulation of JAK\/STAT1 signaling and correlates with reduced inflammation in tuberculosis patients. Front. Immunol. 13, 923492 (2022).","journal-title":"Front. Immunol."},{"issue":"1","key":"98152_CR19","doi-asserted-by":"publisher","first-page":"23","DOI":"10.4103\/ijmr.IJMR_2055_16","volume":"150","author":"D Bisht","year":"2019","unstructured":"Bisht, D. & Meena, L. S. Adhesion molecules facilitate host\u2013pathogen interaction and mediate Mycobacterium tuberculosis pathogenesis. Indian J. Med. Res. 150(1), 23\u201332 (2019).","journal-title":"Indian J. Med. Res."},{"issue":"1","key":"98152_CR20","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/s41541-024-00834-y","volume":"9","author":"S Chugh","year":"2024","unstructured":"Chugh, S. et al. Antigen identification strategies and preclinical evaluation models for advancing tuberculosis vaccine development. NPJ Vaccines 9(1), 57 (2024).","journal-title":"NPJ Vaccines"},{"issue":"1","key":"98152_CR21","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/s41541-023-00710-1","volume":"8","author":"S Krishnananthasivam","year":"2023","unstructured":"Krishnananthasivam, S. et al. An anti-LpqH human monoclonal antibody from an asymptomatic individual mediates protection against Mycobacterium tuberculosis. NPJ Vaccines 8(1), 127 (2023).","journal-title":"NPJ Vaccines"},{"issue":"5","key":"98152_CR22","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1038\/s12276-021-00632-9","volume":"53","author":"G Choi","year":"2021","unstructured":"Choi, G. et al. A critical role for Th17 cell-derived TGF-beta1 in regulating the stability and pathogenicity of autoimmune Th17 cells. Exp. Mol. Med. 53(5), 993\u20131004 (2021).","journal-title":"Exp. Mol. Med."},{"issue":"3","key":"98152_CR23","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/cmi.2017.128","volume":"15","author":"H Shen","year":"2018","unstructured":"Shen, H. & Chen, Z. W. The crucial roles of Th17-related cytokines\/signal pathways in M. tuberculosis infection. Cell. Mol. Immunol. 15(3), 216\u2013225 (2018).","journal-title":"Cell. Mol. Immunol."},{"issue":"9","key":"98152_CR24","doi-asserted-by":"publisher","first-page":"4961","DOI":"10.1128\/IAI.70.9.4961-4967.2002","volume":"70","author":"A Blumenthal","year":"2002","unstructured":"Blumenthal, A. et al. Control of mycobacterial replication in human macrophages: Roles of extracellular signal-regulated kinases 1 and 2 and p38 mitogen-activated protein kinase pathways. Infect. Immun. 70(9), 4961\u20134967 (2002).","journal-title":"Infect. Immun."},{"issue":"1","key":"98152_CR25","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/s42003-022-03693-2","volume":"5","author":"M Singh","year":"2022","unstructured":"Singh, M. et al. The 1, 2-ethylenediamine SQ109 protects against tuberculosis by promoting M1 macrophage polarization through the p38 MAPK pathway. Commun. Biol. 5(1), 759 (2022).","journal-title":"Commun. Biol."},{"key":"98152_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.987018","volume":"13","author":"S Liang","year":"2022","unstructured":"Liang, S. et al. Immune regulation and emerging roles of noncoding RNAs in Mycobacterium tuberculosis infection. Front. Immunol. 13, 987018 (2022).","journal-title":"Front. Immunol."},{"issue":"47","key":"98152_CR27","doi-asserted-by":"publisher","first-page":"36511","DOI":"10.1074\/jbc.M110.158055","volume":"285","author":"K Bansal","year":"2010","unstructured":"Bansal, K. et al. Src homology 3-interacting domain of Rv1917c of Mycobacterium tuberculosis induces selective maturation of human dendritic cells by regulating PI3K-MAPK-NF-kappaB signaling and drives Th2 immune responses. J. Biol. Chem. 285(47), 36511\u201336522 (2010).","journal-title":"J. Biol. Chem."},{"key":"98152_CR28","doi-asserted-by":"publisher","first-page":"149","DOI":"10.11604\/pamj.2022.41.149.30056","volume":"41","author":"S Odera","year":"2022","unstructured":"Odera, S. et al. Association between human leukocyte antigen class II (HLA-DRB and -DQB) alleles and outcome of exposure to Mycobacterium tuberculosis: A cross-sectional study in Nairobi, Kenya. Pan Afr. Med. J. 41, 149 (2022).","journal-title":"Pan Afr. Med. J."},{"issue":"4","key":"98152_CR29","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1084\/jem.20151764","volume":"213","author":"D Langlais","year":"2016","unstructured":"Langlais, D., Barreiro, L. B. & Gros, P. The macrophage IRF8\/IRF1 regulome is required for protection against infections and is associated with chronic inflammation. J. Exp. Med. 213(4), 585\u2013603 (2016).","journal-title":"J. Exp. Med."},{"issue":"3","key":"98152_CR30","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.cell.2022.12.038","volume":"186","author":"J Rosain","year":"2023","unstructured":"Rosain, J. et al. Human IRF1 governs macrophagic IFN-gamma immunity to mycobacteria. Cell 186(3), 621\u2013645 (2023).","journal-title":"Cell"},{"issue":"15","key":"98152_CR31","doi-asserted-by":"publisher","first-page":"7270","DOI":"10.1111\/jcmm.16756","volume":"25","author":"L Wu","year":"2021","unstructured":"Wu, L. et al. IRF1 as a potential biomarker in Mycobacterium tuberculosis infection. J. Cell. Mol. Med. 25(15), 7270\u20137279 (2021).","journal-title":"J. Cell. Mol. Med."},{"key":"98152_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.716809","volume":"11","author":"F Yi","year":"2021","unstructured":"Yi, F. et al. Transcriptional profiling of human peripheral blood mononuclear cells stimulated by Mycobacterium tuberculosis PPE57 identifies characteristic genes associated with type I interferon signaling. Front. Cell. Infect. Microbiol. 11, 716809 (2021).","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"10","key":"98152_CR33","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.136937","volume":"5","author":"TR Lerner","year":"2020","unstructured":"Lerner, T. R. et al. Mycobacterium tuberculosis cords within lymphatic endothelial cells to evade host immunity. JCI Insight 5(10), e136937 (2020).","journal-title":"JCI Insight"},{"issue":"160","key":"98152_CR34","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0377-2020","volume":"30","author":"I Kontsevaya","year":"2021","unstructured":"Kontsevaya, I. et al. Perspectives for systems biology in the management of tuberculosis. Eur. Respir. Rev. 30(160), 200377 (2021).","journal-title":"Eur. Respir. Rev."},{"issue":"2","key":"98152_CR35","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1111\/imm.13277","volume":"162","author":"A Walters","year":"2021","unstructured":"Walters, A. et al. TNFRp75-dependent immune regulation of alveolar macrophages and neutrophils during early Mycobacterium tuberculosis and Mycobacterium bovis BCG infection. Immunology 162(2), 220\u2013234 (2021).","journal-title":"Immunology"},{"issue":"1","key":"98152_CR36","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/s41590-020-00845-6","volume":"22","author":"M Divangahi","year":"2021","unstructured":"Divangahi, M. et al. Trained immunity, tolerance, priming and differentiation: Distinct immunological processes. Nat. Immunol. 22(1), 2\u20136 (2021).","journal-title":"Nat. Immunol."},{"issue":"3","key":"98152_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.imbio.2020.151951","volume":"225","author":"J Ferluga","year":"2020","unstructured":"Ferluga, J. et al. Natural and trained innate immunity against Mycobacterium tuberculosis. Immunobiology 225(3), 151951 (2020).","journal-title":"Immunobiology"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-98152-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-98152-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-98152-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T02:23:00Z","timestamp":1745893380000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-98152-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,29]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["98152"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-98152-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,29]]},"assertion":[{"value":"8 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by Ethics Committee of the First Affiliated Hospital of Xinjiang Medical University (No. K202304-29).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"14986"}}